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Abstract
Background: Adipocyte numbers and peroxisome proliferators activated receptorg (PPARg) expression of
retroperitoneal tissue increased while area under the curve (AUC) during the glucose tolerance test (GTT) was
reduced in rats subjected to certain feed withdrawal (FW) regimens. Thus, using pigs as the experimental model,
the hypothesis that FW regimens influence glucose tolerance by influencing fat cell function was evaluated with
the objective of determining the effect of a single (FWx1; at age of 19 wk for 48 h) or periodic, multiple (FWx4; 24
h FW at 7 and 11 wk of age and 48 h FW at 15 and 19 wk of age) FW on AUC of glucose and insulin during the
GTT relative to pigs that did not experience FW (Control).
Methods: Growth, body composition, adipocyte numbers, PPARg expression, lipogenic potential as glucose uptake
into fat of adipocytes of varying diameter in omental (OM) and subcutaneous (SQ) fat as affected by FW regimens
were determined in pigs initiated into the study at 5 wk of age and fed the same diet, ad libitum.
Results: Blood glucose concentrations for prior to and 120 min post glucose meal tended to be lower (p = 0.105
and 0.097, respectively) in pigs in FW treatments. In OM fat; cell numbers, glucose Universal
14C[ U
14C] incorporation
into fat and rate of incorporation per 10
4 cells was greatest for cells with diameters of 90-119 μm. Pigs undergoing
FWx4 tended to have greater (p = 0.0685; by 191%) number of adipocytes, increased (p = 0.0234) glucose U
14C
incorporation into adipocytes and greater (p = 0.0872) rate of glucose uptake into cells of 119-150 μm diameter
than of cells from control or FWx1 pigs. Subcutaneous adipocyte numbers in 22-60 and 61-90 μm diameter ranges
from pigs in FWx1 tended to be greater (p = 0.08 and 0.06, respectively) than for those in FWx4 treatment, yet
PPARg expression and total cell number were not affected by treatment.
Conclusions: Results suggest that FW regimens influence fat cell function or lipogenesis rather than number,
affecting glucose metabolism and may have implications in drug-free control of metabolic syndrome symptoms.
Keywords: Adipocyte diameter, area under the curve, glucose tolerance, glucose incorporation into fat, pigs, feed
withdrawal
Background
The increase in incidence of clinical disorders that arise
from metabolic syndrome has led to substantial research
investment in this area, resulting in significant develop-
ments in the understanding of the progression of the
syndrome. The manifestation of metabolic syndrome
symptoms may not be related to obesity alone [1], but
could be associated with the ability of adipose tissue to
synthesize fat or be functional in maintenance of ener-
g e t i ch o m e o s t a s i si nt h eb o d ya n do p e r a t ea sab u f f e r
between consumed energy and that utilized for life
activities [2]. Contrary to earlier observations [3] it is
n o wh y p o t h e s i z e dt h a tl i p i d -saturated adipocytes, of
relatively larger diameter (greater than 135 μm), have
compromised lipogenic potential with poor buffering
action leading to increased blood lipids, and perhaps
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ectopic lipid deposition along with manifestation of adi-
pose tissue inflammation resulting in insulin resistance
[4]. Protection against inflammation, thus insulin resis-
tance in humans appears to reside in the enzymatic abil-
ity of adipocytes to synthesize fat [5]. Inability to
synthesize and store fat, as in lipodystrophic non-obese
humans and mice, led to development of insulin resis-
tance [6], while adipose tissue transplants into these
mice alleviated symptoms of hyperglycemia, hyperinsuli-
nemia and dyslipidemia [7,8], suggesting that the reten-
tion of the ability to enhance adipocyte differentiation
or lipogenic potential can be protective against insulin
resistance. Similarly, decline in insulin resistance in thia-
zolidinedione treated type-2 diabetics appears to be
mediated via increase in adipocyte differentiation [9].
The preceding review suggests that protocols that
increase adipocyte numbers with lipogenic capacity
could abate progression of metabolic syndrome in
humans by increasing the energy buffering or functional
capacities of adipocytes.
Adipocyte numbers tended to increase in intramuscu-
lar and subcutaneous adipose tissues of beef cattle sub-
jected to a single feed withdrawal (FW) for 48 h prior to
initiation of the fattening phase [10] with positive eco-
nomic returns due to elevated quality grades. Although it
has been known that feed restriction (provision of energy
deficient diets) followed by ad libitum feeding enhances
production efficiency of livestock [11], the effect of FW
for 48 h prior to start of the fattening phase on adipocyte
number in intramuscular fat was first addressed by Mir
et al. [10]. While effects of fasting have been studied in
the rat, as models for humans [12,13], the focus has been
on lipoprotein lipase activity. However, He et al. [14]
reported that fa/fa obese rats; that underwent fortnightly
feed withdrawal for 24 h, had increased expression of the
adipocyte marker; peroxisome proliferator-activated
receptorg (PPARg) along with a 13% increase in total cell
density in the retroperitoneal adipose tissue. He et al.
[14] reported a significant, quadratic relationship
between average cell diameter of the retroperitoneal tis-
sue and the area under the curve (AUC) for glucose dur-
ing a glucose tolerance test (GTT) in Wistar male rats.
As a result of these observations the authors suggested
that glucose management relied on fat synthetic activity
of adipocytes, which was a function of both; adipocyte
density and size. To date no investigation has addressed
the effect of FW regimens, on adipocyte characteristics
and consequently on symptoms of metabolic syndrome
in pigs even though pigs could be ideal as models for
humans for the study of metabolic syndrome [15]. The
present study was conducted to determine whether FW
regimens would alter adipocyte number and size (dia-
meter) in the omental (OM) and subcutaneous (SQ)
adipose tissues, and if these factors influenced AUC of
glucose and insulin during a GTT. Furthermore, it was
crucial to determine if FW regimens affected glucose
incorporation into fat [4] in OM and SQ adipose tissues
in cells that were divided into five diameter ranges from
22 to 288 μm [14,16] rather than three ranges from 20 to
150 μm [4] and whether cell number and cell diameter
were affected. The effect of FW regimen on PPARg
expression in the adipose tissues was necessary because it
is recognized as an index of an increase of insulin sensi-
tive adipocytes, which appear to control progression of
metabolic syndrome [17]. Thus the hypothesis that
reductions of AUC for glucose during a GTT could be
achieved through FW regimen because of an effect on
lipogenic potential was evaluated. The objectives of the
present investigation, were to determine the effects of a
single FW (FWx1) for 48 h at 19 wk of age or multiple
FW (FWx4) for 24 h at seven and 11 wk and for 48 h at
15 and 19 wk of age in castrated pigs between the ages of
5 and 23 wk as models for humans on growth of pigs,
body composition, OM and SQ adipose tissue cellularity
by adipocyte diameter (μm), glucose incorporation into
fat and AUC for glucose and insulin.
Methods
Animals and treatments
An experiment was conducted with 27, weanling,
castrated, 5 wk old pigs after obtaining the approval of
Lacombe Research Centre Animal Care Committee
(approval number: 20901) of Agriculture and Agri-
Food Canada. The pigs were cared for according to the
guidelines of the Canadian Council on Animal Care
[18]. The 27 pigs were individually housed in pens
with slatted floors in rooms maintained on a 12 h
light:dark cycle at 18°C. The pigs in all FW treatments
were provided with the same diet and were exposed to
pre-grower, grower and finisher rations produced by
Wetaskiwin Co-op feeds, Wetaskiwin, Alberta to meet
or exceed recommendations detailed by the National
Research Council [19]. Feed protein concentrations
ranged between 23.7 and 13.2% based on weight of the
pigs and the digestible energy available from the diet
was 340 Kcal/100 g of diet derived from cereals and
protein supplements.
The castrated pigs were progeny of Large White X
Landrace crossbred females that were bred to Durok
boars, and were obtained from Hypor Comp (Alberta).
T h ep i g sw e r ep r o v i d e df e e da n dw a t e ra dl i b i t u ma n d
allowed to acclimatize to the barn for 2 wk. The following
day, pigs were weighed, randomized by weight to the three
treatments at nine pigs per treatment as a completely ran-
domized design experiment. The treatments assigned to
the weanling pigs were as described in the schematic in
Figure 1.
Mir et al. Nutrition & Metabolism 2012, 9:10
http://www.nutritionandmetabolism.com/content/9/1/10
Page 2 of 12Post acclimatization, at initiation of the experiment, the
pigs were weighed and placed in pens with cleaned feed
bunks and those in the FWx4 treatment were not pro-
vided feed. After 24 h the feed was provided to the pigs
in treatment FWx4. The pigs in the no FW (control) and
F W x 1t r e a t m e n t sw e r ep r o v i d e df e e da dl i b i t u mp o s t
weighing. All pigs had free access to water at all times.
The pigs were weighed every 4 wk. After the weight was
recorded, the pigs in the FWx4 treatment were denied
feed for 24 h at 11 wk and for 48 h at 15 and 19 wk of
age. The pigs in the FWx1 treatment were denied feed
for 48 h post weighing at the age of 19 wk. The pigs were
maintained in experiment for 18 wk or until the age of
23 wk. The GTT was conducted during the 16
th wk of
the experiment, at the rate of three pigs each day, in nine
pigs with three pigs randomly selected from each treat-
m e n t .A t2 3w ko fa g eo ra f t e r1 8w ki ne x p e r i m e n tt h e
pigs were euthanized in a federally inspected abattoir (3
pigs/d/treatment within the wk) and samples of OM and
SQ adipose tissue and of the longissimus muscle were
procured within 15 min of exsanguination for determina-
tion of glucose Universal
14C[ U
14C] incorporation into
fat and adipocyte enumeration and molecular marker
PPARg in the tissues.
Glucose tolerance test (sub-experiment 1)
The GTT was conducted in nine pigs when they were of
21 wk old or during the 16
th wk of the experiment. Pigs
were catheterized for ease of blood sampling one day prior
to the test. An indwelling ear vein catheter (Intramedic
tubing, PE 90, 0.86 mm and 1.17 mm internal and outer
diameter, respectively; Becton Dickinson; Parsippany, N.J.)
was inserted under aseptic conditions approximately 20
cm intravascularly. A pig from each treatment was fasted
for 24 h and the blood was collected to obtain fasting
blood for glucose and insulin determination, after which
the glucose was provided in a small amount of feed and
the time for complete consumption of the feed was moni-
tored, which was always less than 15 min. Glucose was
provided at 1.4 g/kg bodyweight. Blood samples were col-
lected for determination of glucose and insulin concentra-
tion in the blood and plasma, respectively. Blood was
drawn prior to and after 5, 15, 30, 45, 60, 90, 120, and 150
min post ingestion of the glucose meal. Blood glucose was
determined using a hand held glucometer (MediSense,
Abbot Laboratories, Montreal, QC., Canada) and Precision
Xtra blood glucose strips (MediSense, Abbot Laboratories,
Montreal, QC., Canada) [20,21] prior to and post con-
sumption of the glucose meal. The glucose concentration
was plotted against time and the area under the curve
(AUC) was calculated as AUCGround (AUCG mmol/L *
min; [22]). At the times of blood collection for blood glu-
cose measurement, samples were obtained for determina-
tion of plasma insulin concentration. Approximately
10 mL of blood was collected in evacuated tubes (Beckton
and Dickenson, Mississauga, ON, Canada) containing
potassium EDTA and placed on ice. The blood was centri-
fuged at 600 × g for 10 min at 5°C and the plasma was
separated and frozen until the samples were analyzed for
insulin concentration. Insulin concentration in plasma was
determined using the porcine insulin kit (Bio Vendor with
catalogue #RSHAKRIN013TR for Shibayagi Co. Ltd.,
Gunma Japan ELISA kit) and the CV for the control used
in the estimation was 8.28. The AUCG for insulin was
determined as for glucose [22]. The fasting glucose and
insulin concentrations were used to calculate the homeo-
static model assessment (HOMA) index for the pigs [23].
Cellularity and glucose incorporation into fat
At euthanasia tissue samples were collected from the
OM and the SQ and glucose incorporation into fat was
evaluated by measuring uptake of glucose universal
14C
[U
14C] as counts per minute (CPM) into the fat
extracted from the cells from each tissue [4]. Briefly
each tissue sample from each animal was collected and
placed in Tris sucrose buffer at 37°C (30 mM Tris-HC1,
0.3 M sucrose, 1 mM EDTA, 1 mM glutathione; pH 7.4
at 37°C) and transported to the radioactive laboratory
for incubation. Samples of adipose tissue of 200-300 μm
in thickness were cut, rinsed twice with buffer without
EDTA (30 mM Tris-HC1, 0.3 M sucrose, 1 mM glu-
tathione; pH 7.4 at 37°C) and approximately 100-150
mg of tissue was placed in 25 mL test tubes for subse-
quent incubation.
Duplicate adipose tissue slices were incubated in
25 mL test tubes which contained 3 mL of Krebs-Ringer
bicarbonate (KRB) buffer, pH 7.4, with half the calcium
and 30 mg/mL of fat free, de-colourized bovine serum
albumin. The KRB buffer also contained 10 μMo fg l u -
cose (Vmax for substrate concentration) and 0.3 μCi/mL
of glucose U
14C (New England Nuclear Waltham Mas-
sachusetts, USA). The test tubes were flushed with O2:
CO2, (95:5), sealed with a rubber serum cap, and incu-
bated at 37°C for 2 h in a shaking water bath. Following
incubation, tissue slices were rinsed three times in 37°C,
0.154 M NaCl, and once in 3 mL of 50 mM collidine-
HCl buffer, pH 7.4, blotted carefully, and weighed into
vials containing 2 mL of 3% osmium tetroxide in colli-
dine buffer for fixation of cells [24] and held at room
Weanling pigs 
Control (no feed withdrawal (FW); n=9) 
Single FW for 48h at age 19wk (FWx1, n=9) 
Multiple FW (FWx4; n=9) for 24h at 7 and 11wk 
and 48h FW at 11 and 19wk 
Figure 1 Schematic for application of feed withdrawal (FW)
treatments.
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that all the tissue was fixed. After the 96 h, the osmium
tetroxide was removed and 10 mL of 0.154 M NaCl was
added and held at room temperature for 24 h after
which the 0.154 M NaCl was removed and 10 mL of
8 M urea in 0.154 M NaCl was added and the tissue
allowed to soften for 48 h or until cells were liberated
f r o mt h et i s s u em a t r i x .T h eu r e aw a sr e m o v e da n d
10 mL of distilled water was added and the cells were
transferred to 50 mL tubes followed by 3 washes of,
5 mL aliquots of 0.154 M NaCl, pH 10 to rinse the cells
completely into the tubes. Fixed adipocytes were sepa-
rated into five sizes based on diameter to determine cel-
lularity and measure glucose incorporation as CPM in
fat extracted from the cells separated by diameter size.
Cell fractionation into five diameter ranges
Nitex material (Sefar Canada, St. Laurent, Qc) with open-
ings of 280, 150, 118, 90, and 60 μm were used to succes-
sively filter the cells released from the fixed fat tissue
samples and cells remaining over the nitex post filtration
was collected with each of 3 washes of 2 mL 0.154 M
NaCl. The filtration process divided the cells into fractions
of cells in diameter ranges of 151-288, 119-150, 91-118,
61-90 and less than 60 μm. The cell material remaining on
the 288 μm nitex was discarded. Cell numbers in each
fraction were determined by computer image analysis
(Motic Images Plus 2.0 ML, Motic China Group Co. Ltd.,
Xiamen, China) [14] of 1 mL of the adipocyte suspension
in a Sedgwick-Rafter counting chamber (Thomas Scienti-
fic, Swedesboro, NJ) [25]. The adipocyte suspension was
prepared by adding an equal volume of glycerol to each
cell suspension and further dilutions if necessary were pre-
pared by adding known and required volumes of 40% gly-
cerol in 0.154 M NaCl. All the dilution factors applied to
each cell suspension were recorded and used in determi-
nation of cell number within each diameter range for each
sample.
Measurement of radioactivity
The cell fractions by diameter range collected from filtra-
tion were drained free of the glycerol-saline and rinsed
with distilled water to remove the glycerol and the suspen-
sion was rinsed into a glass scintillation vial with water.
The water was evaporated in a heating block (Pierce
Reacti-Therm III Heating Module; Rockford, IL, 61105) at
60°C until approximately 1 mL remained. In order to
remove the Osmium tetroxide 3 mL of hydrogen peroxide
(30%) was added to each cell suspension and heated in the
block heater (in a ventilated fume hood) to volatilize
Osmium tetroxide from the adipocytes. This was repeated
to ensure total loss of color followed by evaporation of
water until approximately 1 mL remained. The samples
were cooled and the fat in the decolorized cells was
extracted by vortexing with 2 mL of chloroform and 1 mL
of methanol for 30 s. The samples were centrifuged and
the chloroform layer was collected into scintillation vials.
The extraction was repeated to ensure complete extraction
of the fat in the cells. The chloroform was evaporated
under a stream of nitrogen then 4 mL of Ultra-Gold scin-
tillation cocktail was added, vortexed at high speed for 30
s and the Beta counts were measured using the Beckman
Liquid Scintillation System LS 6000 IC (Beckman Inst.
Inc. Fullerton, CA) and the CPM in fat was calculated for
cells in each diameter range per mg of sample fixed and
per 10
4 cells. In order to determine the glucose incorpora-
tion into fat, the average of the blank CPM, collected three
times during each day of measurement (3d) were first
deducted from the CPM of the fat extracted from the
cells, which represented incorporation of D- glucose [U
14C] into total lipid and the radioactivity was measured for
each cell fraction from the cells from the original weight
of the tissue incubated.
RNA isolation
Omental fat was collected from the abdominal region of
adult swine at the time of euthanasia in RNase later
(Ambion) and frozen at -80°C. RNA was isolated from the
fat using the Aurum total RNA fatty and fibrous tissue kit
(Biorad). The kit includes a preliminary DNase clean up
step to insure no genomic DNA contamination.
The RNA samples were quantified spectrophotometri-
cally at 260 nm. All RNA isolates had an OD260:OD280
between 1.8 and 2.0, indicating clean RNA isolates. The
RNA quality was also checked for the presence of 28S and
18S rRNA band on 1.0% agarose gel electrophoresis
stained with 1 μg/mL ethidium bromide.
Relative reverse transcriptase - polymerase chain reaction
(RT-PCR) analysis
A two step quantitative reverse transcriptase (RT-PCR)
method was used to measure gene expression in the sam-
ples. In the first step, cDNA synthesis was made from
total RNA (5 ug) with 0.5 μM oligo-dT, 0.2 μMr a n d o m
hexamer primers, 500 μMo fe a c hd N T P sa n dH 20a n d
preheated at 65°C for 2 min to denature secondary struc-
tures. The mixture was then cooled rapidly to 20°C, then
10 μL 5× RT Buffer, 1 unit/μlo fR n a s ei n h i b i t o ra n d
200 U MMLV Reverse Transcriptase (Sigma-Aldrich,
Oakville, ON, Canada) was added for a total volume of
50 μL. The RT mix was incubated at 37°C for 90 min.
then stopped by heating at 95°C for 5 min. The cDNA
stock was stored at -20°C. The yield of cDNA was mea-
sured according to the glycerol-3-phosphate dehydrogen-
ase (GADPH) [SSU97256] 5’-atctgtgaccagctcaagg-3’ and
5’-gcaggaggtggacacagt-3’ and beta-actin [AY550069]
5’-acatcaaggagaagctgtgc-3’ and 5’-gcaaggacctctacgccaa-3’
polymerase chain reaction (PCR) signal, generated on a
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dye detection. Good amplification was determined to be
detection in 18 to 22 cycles, starting with 0.1 μLo ft h e
cDNA solution in 20 μl of the Quantiech SYBR green kit
with 5 pmole of forward and reverse primers of either the
GADPH or beta-actin. PCR products were examined after
real-time detection by electrophoresis for 2 h at 70 v on
native 10% polyacrylamide gels stained with 1 μg/mL ethi-
dium bromide. Genomic DNA contamination was indi-
cated by a 354 bp band and cDNA was indicated by a 256
bp band in the beta-actin amplification. Gene expression
of the PPARg was measured by real-time PCR in a SYBR
green reactions using the forward 5’- ataaagtccttccgctgac-
3’ and reverse 5’-gtatgccaagaacatccctg-3’ primers. Gene
expression was calculated using GADPH as the reference
point, to standardize the data according formula Ct (sam-
ple) - Ct (reference) and reported as percent of control.
Growth hormone (sub-experiment 2)
At time of euthanasia of the pigs, blood was collected
into K-EDTA containing tubes from four pigs in the
control treatment and another set of four pigs that were
n o tp a r to ft h ee x p e r i m e n t( s p a r e s )b u th a db e e ns u b -
jected to FW for 48 h prior to euthanasia and were
similarly processed. The plasma was harvested from the
blood and analyzed for porcine growth hormone (Cedar-
lane product #E0044PO from USCN Life Science Inc,
Wuhan China). The CVs for the growth hormone values
ranged from 0.9 to 16.0 among the animals that under-
went FW and from 6.2 to 12.5 for the samples from the
animals in the control treatment.
Statistical analysis
The data from the experiment were analyzed as a com-
pletely randomized design experiment [26] using PROC
MIXED of SAS (SAS Inst., Cary, NC, 2005). Data from
the pigs were analyzed for variance and mean separation
using Least Square Difference [26] was applied only if
the F-value was significant for treatments. The experi-
mental unit was the pig because they were individually
penned and all data were collected for each pig. Correla-
tion coefficients between AUC for glucose and insulin
from the GTT versus glucose and insulin concentrations
at the times of sampling were determined. For the glu-
cose [U
14C] uptake study only values from pigs where
the sample size incubated was less than the 160 mg was
included in the data analysis, thus the replication for
this aspect of the study for the control, FWx1 and
FWx4 treatments was five, six and seven, respectively
for the OM tissue and seven, six and seven for SQ tissue
respectively. Samples incubated for glucose uptake from
most (six out of nine) of the pigs that were used for the
GTT was larger than the 160 mg as a result these were
not included and cellular effects on GTT parameters
could not be studied. Values are expressed as mean ±
SEM and differences were considered significant at p <
0.05, while values between p > 0.05 < 0.1 were consid-
ered as expressing a trend. Difference between average
target mRNA for PPARg and GADPH levels were com-
pared between each other and among treatments to
yield a p value using ANOVA analysis.
Results
Growth and body composition
Treatment intervention applied was modest, thus differ-
ences in growth characteristics such as body weight
were not expected and were not observed (Table 1). Dif-
ferences among treatments were also not observed for
body composition factors (Table 2),
Glucose tolerance test
The blood glucose and insulin concentrations during the
GTT are provided in Figures 2 and 3, respectively. Dif-
ferences due to the FW treatment were not significant
at any sampling time for either glucose or insulin. Only
trends (p = 0.1048 and 0.0968) towards lower values
were observed for blood glucose concentrations for sam-
ples collected prior to and 120 min post glucose meal
consumption for samples collected from pigs in the
FWx4 treatment. Despite these differences in blood glu-
cose concentration, differences were not significant for
glucose and insulin concentration, HOMA values or glu-
cose and insulin AUC (Table 3).
Correlation coefficients among GTT factors
The AUC glucose was significantly related to AUC insu-
lin, blood glucose concentrations at 30, 45 and 60 min
and plasma insulin concentrations at 45 and 90 min
post glucose meal consumption (Table 4). The AUC for
insulin was in turn correlated to AUC for glucose and
blood glucose and plasma insulin concentrations at 30,
45 and 60 min post the glucose meal consumption, sug-
gesting that blood glucose concentration 45 min post
g l u c o s em e a li naG T Tw a sv a l u a b l ei na s s e s s i n gt h e
AUC for both glucose and insulin. The AUC for insulin
was also correlated to the plasma insulin concentrations
prior to glucose meal consumption.
Adipose tissue cellularity and glucose incorporation into
fat
In the OM adipose tissue differences among treatments
were not observed (p > 0.05) for cell numbers in any of
the diameter ranges studied, due to large variances,
which may be due to the innate variation among the
pigs, minimal replication and the extensive handling of
the samples. As is evident in Figure 4a, the largest pro-
p o r t i o no fc e l l sw a si nt h e9 1 - 1 1 8μm diameter range,
but differences due to FW treatment were not
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191% greater (p = 0.0685) number of cells in the dia-
meter range of 119-150 μm than the cells in pigs in the
control treatment.
No difference in glucose incorporation into fat, mea-
sured as CPM from
14Cf r o mg l u c o s eU
14Ci n c o r p o r a -
tion into fat from the cells was noted for FW treatments,
except for cells in the range of 119-150 μm( F i g u r e4 b ) ,
where the CPM of fat from 1.0 mg of sample was 223%
greater (p = 0.0234) than that of cells from pigs in the
control or FWx1 treatment. The highest CPM for fat
from cells/mg of sample was noted for cells in the 91-118
μm diameter range, but differences due to FW treatment
were not significant. Similarly the rate of glucose uptake
as CPM/10
4 cells was greatest for cells in the diameter
range of 91-118 μm( F i g u r e4 c )b u tt r e a t m e n te f f e c t s
were obscured due the variation. However, the rate of
glucose uptake for the cells in the 119-150 μm diameter
Table 2 Body composition characteristics of 23 wk old castrated pigs in control and feed withdrawal (FW) treatments.
Treatments Probability
Factor Control FWx1 FWx4 value
n9 9 9
Slaughter weight (Wt), kg 133.8 ± 3.0 136.3 ± 1.9 138.7 ± 3.4 0.4861
Hot carcass Wt, kg 111.2 ± 2.2 113.4 ± 1.6 115.2 ± 2.8 0.4434
Kidney fat (kg) 3.1 ± 0.2 2.9 ± 0.2 3.1 ± 0.2 0.7021
Carcass fat depth (mm) 24.0 ± 0.5 26.3 ± 1.1 26.9 ± 1.2 0.1238
Carcass lean depth (mm) 56.0 ± 1.0 58.6 ± 1.2 58.6 ± 1.6 0.2807
Lean yield estimate (%) 58.0 ± 0.2 57.5 ± 0.4 57.3 ± 0.4 0.2404
Yield/100 kg slaughter, Wt 94.4 ± 5.8 86.9 ± 7.5 74.3 ± 8.4 0.1668
Molecular marker; Muscle
PPARg - GADPH (% of control) 100 ± 150ab 267 ± 154a 57 ± 153b 0.0516
Total adipocyte number in muscle
Cells/mg of muscle fat 860 ± 204.9 890 ± 9.0 754 ± 144.7 0.8339
Cells/mg of muscle 663 ± 158 748 ± 140.1 560 ± 135.0 0.6607
Control (no FW),
Single feed withdrawal (FWx1) for 48 h at 19 wk of age
Multiple feed withdrawal (FWx4) for 24 h at age 7 and 11 wk and for 48 h at 15 and 19 wk treatments
Values are expressed as mean ± SEM.
Carcass fat and lean depth - Destron system [37]
The fat depth measurement location is between the 3
rd and 4
th last ribs, 7.0 cm over from the midline.
The instrument used for grading was the Anitech PG-100 grading probe (Anitech Information System Inc., Markham, Ontario).
The % estimated lean yield is based on a quadratic equation which is also used as a reference for slaughter plants:
(68.1863-0.7833(F) + 0.0689(M) + 0.0080(F
2) - 0.0002(M
2) + 0.0006(FM). Where F is fat thickness in mm and M is muscle thickness in mm.
Table 1 Growth factors of 23 wk old castrated pigs in control and feed withdrawal (FW) treatments.
Treatments Probability
Factor Control FWx1 FWx4 value
n9 9 9
Initial weight (Wt, kg) 13.7 ± 0.8 13.4 ± 0.4 14.6 ± 0.6 0.4057
Wt at 28 d kg 34.0 ± 1.8 36.0 ± 1.1 36.5 ± 1.1 0.4170
Wt at 56 d kg 63.7 ± 2.5 66.9 ± 1.8 67.6 ± 2.1 0.4037
Wt at 84 d kg 96.6 ± 2.8 100.3 ± 2.0 101.2 ± 2.9 0.4202
Wt at 124 d kg 135.8 ± 3.1 138.6 ± 1.9 140.6 ± 3.2 0.4122
Total wt gain kg 122.0 ± 2.6 125.0 ± 1.7 126.4 ± 3.0 0.4476
ADG kg 1.02 ± 0.02 1.05 ± 0.02 1.06 ± 0.02 0.4785
Total feed intake kg 339.2 ± 10.5 346.1 ± 8.3 358.3 ± 12.1 0.4355
Dry feed intake kg/d 2.8 ± 0.08 2.9 ± 0.07 3.0 ± 0.09 0.4095
Gain: feed 0.36 ± 0.01 0.36 ± 0.01 0.36 ± 0.01 0.7698
Control (no FW),
Single feed withdrawal (FWx1) for 48 h at 19 wk of age
Multiple feed withdrawal (FWx4) for 24 h at age 7 and 11 wk and for 48 h at 15 and 19 wk treatments
Values are expressed as mean ± SEM.
ADG Average daily gain
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Page 6 of 12range, from the pigs in the FWx4 treatment tended (p =
0.0872) to be higher than that of the pigs in either the no
FW (control) or the FWx1 treatments by 173 and 139%,
respectively.
In the SQ tissue (Figure 5 a. b. c) the FW treatments
tended (p = 0.0773 and 0.0613) to affect cell number in
the diameter ranges of 22-60 and 60-90 μm, where the
pigs in the FWx1 had 305 and 233% greater number of
cells, respectively than those in the FWx4 treatment.
Unlike that observed for the OM tissue, the cell number
appeared to be distributed more evenly among the dia-
meter ranges of 60-118 μm. Glucose uptake as CPM of
fat/mg of sample or rate of glucose incorporation were
not affected by treatment.
PPARg expression
The molecular marker PPARg expression was deter-
mined with respect to the house keeping gene GADPH,
to substantiate observations from the cellularity determi-
nations. Although differences in total cell count from
muscle were not affected by the FW treatment (Table 2)
there was increased expression of PPARg in muscle of
pigs that underwent the FWx1 relative to those that
underwent the FWx4 treatment but not relative to that
in pigs in the control treatment. No differences in mar-
ker expression or cells/mg tissue in OM fat were
observed in the present work (Figure 3a; Table 3). The
PPARg expression in SQ tissue was not undertaken and
it was the only location where a trend towards an
increase in cell numbers was observed for tissues
obtained from pigs in the FWx1 treatment. However,
this increase was noted only for cells with the diameter
ranges of 20-60 and 60-90 μma n dn o tf o rt o t a lc e l l s /
mg.
Growth hormone concentrations
The FW treatment resulted in only relatively elevated
values for porcine growth hormone of 3.26 ± 1.49 ng/
mL while the value was 1.74 ± 0.74 ng/mL for the pigs
from the control treatment indicating that growth hor-
mone had no major involvement in altering the cell
number and mirrored the effect observed for the mole-
cular marker for adipocytes.
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Figure 2 Blood glucose concentration curves during the
glucose tolerance test of castrated pigs at 21 wk of age
undergoing control (no feed withdrawal), single feed
withdrawal (FWx1) for 48 h at 19 wk or multiple feed
withdrawal (FWx4), FW for 24 h at age 7 and 11 wk and for 48
h FW at 15 and 19 wk. Trends (p = .1048 and .0968) towards
decreased glucose concentrations were observed for fasting and
120 min post glucose consumption samples respectively from pigs
in the FW treatments relative to values for pigs in the control
treatment (n = 3).
Table 3 Glucose tolerance test factors and area under the curve (AUCground) for glucose and insulin during the glucose
tolerance test conducted in 21 wk old castrated pigs in control and feed withdrawal (FW) treatments.
Treatments Probability
Factors Control FWx1 FWx4 value
n3 3 3
Fasting glucose mM/L 4.64 ± 0.03 3.83 ± 0.41 3.85 ± 0.15 0.1048
Fasting Insulin μU/mL 11.02 ± 6.39 4.88 ± 2.51 7.65 ± 7.66 0.7716
HOMA index 2.28 ± 1.32 0.82 ± 0.41 1.26 ± 1.26 0.4844
AUC glucose (mM*min) 870.8 ± 37.1 851.7 ± 80.1 750.4 ± 57.1 0.3815
AUC insulin (ng/ml*min) 469.1 ± 42.5 429.8 ± 96.5 421.3 ± 95.8 0.9099
Omental tissue
Molecular marker
PPARg - GADPH(% of control) 100 ± 23 105 ± 29 126 ± 13 0.1599
Total cell number/mg 1514 ± 171.1 1184 ± 112.6 1257 ± 114.8 0.3911
Control (no FW),
Single feed withdrawal (FWx1) for 48 h at 19 wk of age
Multiple feed withdrawal (FWx4) for 24 h at age 7 and 11 wk and for 48 h at 15 and 19 wk treatments
HOMA - Homeostatis model assessment index - [fasting insulin (μU/mL) * fasting glucose (mM/L)]/22.5
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The lack of effect of the FW regimen on the growth
characteristics of pigs was expected and is similar to
that observed in rats [14] and cattle [10]. Intramuscular
fat in heifers was increased in those subjected to FWx1
as evidenced by the increase in the percentage of heifers
grading at the elevated grade. The aim of the present
investigation was to determine if FW regimens could
lead to an expansion in adipocyte number to improve
glucose tolerance in the pig model by alleviating lipody-
strophy and to assess application of FW regimens in
humans to control progression of metabolic syndrome
symptoms.
The FW duration (48 h) was similar to that applied in
cattle [10] to insure complete absence of feed in the gas-
trointestinal tract, but when the pigs were 7 and 11 wk of
age the duration of FW was 24 h as in rats [14] to mini-
mize stress in the young animals. Although Liu et al. [27]
imposed a 24 h fast prior to euthanasia in young pigs of
comparable age to study the expression of adiponectin
receptors because of their association to glucose metabo-
lism, they did not study the effects of fasting on factors
that affect glucose metabolism.
In the present study blood glucose appeared to be
responsive to FW in a manner observed in the rats [14],
where only blood glucose concentrations prior to glucose
meal and at the 120 min post glucose meal were
decreased by FWx4 regimen, but the HOMA and AUC
was not affected by treatment. The fact that pre-glucose-
meal values did not indicate a substantial or significant
association with AUC for glucose (Table 4) is important
as this concentration is often used to ascertain metabolic
syndrome status in humans [15]. However the blood glu-
cose concentrations at 45 min post the glucose meal indi-
cated r values of 0.85 to AUC for glucose, furthermore
this value was also highly associated with AUC for insu-
lin. The values in the present study were derived with
only nine pigs and would be worthy of validation because
the type-2 diabetes status with respect to peak glucose
and the AUC appear to influence coronary events and
may be related to the higher incidence of coronary events
in type2-diabetics [15].
Although the associations among glucose tolerance
parameters and cellular factors could not be evaluated
as in He et al. [14], it is evident from the Figure 4 and 5
that only cells ranging from 60 to 150 μmi nd i a m e t e r
in the OM and SQ tissue had increased rates (CPM/10
4
cells) of glucose incorporation into fat relative to cells
with smaller or larger diameters, upholding the hypoth-
esis that cells of median diameter were most active in
lipid synthesis and had the elevated lipogenic potential
to participate in abating metabolic syndrome symptoms.
In concurrence with Etherton et al. [4], differences in
lipogenic activity were not evidenced in cells with dia-
meter ranges between 60 to 150 μm. However in the
present investigation, three diameter ranges within cell
diameters from 60 to 150 μm were studied, while
Table 4 Correlation coefficients for parameters associated
with area under the curve (AUC) for glucose and insulin
during the glucose tolerance test conducted in 21 wk old
castrated pigs from control and feed withdrawal (FW)
treatments.
Parameter Factor Correlation
coefficient
P
value
AUC
Glucose
AUC Insulin 0.6847 0.0419
insulin at 45 min 0.7269 0.0265
insulin at 90 min 0.6711 0.0478
Glucose at 30 min 0.8432 0.043
Glucose at 45 min 0.8504 0.0037
Glucose at 60 min 0.7736 0.0145
AUC Insulin AUC Glucose 0.6846 0.0419
Insulin prior to glucose
meal
0.7152 0.0303
insulin at 30 min 0.8357 0.005
insulin at 45 min 0.9345 0.002
insulin at 60 min 0.6733 0.0468
Glucose at 30 min 0.807 0.0086
Glucose at 45 min 0.7063 0.0335
Glucose at 60 min 0.6805 0.0437
Control (no FW),
Single feed withdrawal (FWx1) for 48 h at 19 wk of age
Multiple feed withdrawal (FWx4) for 24 h at age 7 and 11 wk and for 48 h at
15 and 19 wk treatments
n=9
-2.00
0.00
2.00
4.00
6.00
8.00
10.00
12.00
0 50 100 150 200
min
I
n
s
u
l
i
n
 
n
g
/
m
l
Cont
FWx1
FWx4
Figure 3 Plasma insulin concentration curves during the
glucose tolerance test of castrated pigs at 21 wk of age
undergoing control (no feed withdrawal), single feed
withdrawal (FWx1) for 48 h at 19 wk or multiple feed
withdrawal (FWx4) for 24 h at age 7 and 11 wk and for 48 h at
15 and 19 wk.( n=3 )
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Figure 4 Glucose Universal
14C uptake by cells of different diameter (μm) and from omental adipose tissue of pigs in the feed
withdrawal (FW) treatments: control (no feed withdrawal), single FW (FWx1) for 48 h at 19 wk or multiple FW (FWx4) for 24 h at age
7 and 11 wk and for 48 h at 15 and 19 wk. a. cells per/mg of fat sample, b. counts/min/mg of fat and c. counts/min/10
4 cells. Cell numbers
and U
14C glucose incorporation rate for cells in the diameter range of 119-150 μm tended (p = .0685 and .0872, respectively) to be greater for
pigs in the FWx4 treatment relative to the other treatments, while counts per minute of fat/mg of sample was greater (p = .0234) for the same
cells. (n = 5, 6 and 7 for control, FWx1, and FWx4 respectively)
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Page 9 of 12previously [4], only two cells size groups were consid-
ered within the same diameter range, thus they were
unable to observe the peak in lipogenic activity in cells
in the diameter range of 90 to 118 μm.
The cells from the pigs in the FWx4 treatment
demonstrated elevated glucose uptake when determined
as either CPM of fat from cells/mg of sample or as the
CPM/10
4 cells and may be comparable to the observa-
tions of Fried et al. [12,28], where lipoprotein lipase
activity was elevated in rats that weighed 300 g and
were fasted for 72 h. Co-incidentally pigs in the FWx4
treatment had the lowest AUC for glucose. Although, it
has been cited [29] that periodic fasting as a means of
extending the lives of diabetics was attempted in the
early part of the last century, with marginal success it
has never been scientifically evaluated. The present
study indicates that the adipose tissue expandability [17]
especially of the OM [1] required to abate metabolic
a.  
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Figure 5 Glucose Universal
14C uptake by cells of different diameter (μm) and from subcutaneous adipose tissue of pigs in the feed
withdrawal (FW) treatments: control (no feed withdrawal), single FW (FWx1) for 48 h at 19 wk or multiple FW (FWx4) for 24 h at age
7 and 11 wk and for 48 h at 15 and 19 wk. a. cells per/mg of fat sample, b. counts/min/mg of fat and c. counts/min/10
4 cells. Cell numbers
in the diameter ranges of 22-60 and 60-90 μm tended (p = .0773, .0613 respectively) to be greater for pigs in the FWx1 relative to those in the
FWx4 treatment. (n = 7, 6 and 7 for control, FWx1, and FWx4 respectively)
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Page 10 of 12syndrome symptoms resides in the cells in the diameter
range of 90 to 118 μm and maintenance of this expand-
ability perhaps is possible through regular and periodic
FW for 24 to 48 h.
In pigs the effect of periodic FW on the AUC for glu-
cose appears to be independent of cell number and dif-
ferent from previous observations in rats [14], but the
lack cellular response is concomitant with the non-sig-
nificant response to cell markers investigated in the
study for OM fat.
It is known that GH is a trophic hormone (through
Insulin like Growth Factor) and that feed restriction [30]
in cattle and fasting in humans [31] increases its concen-
tration to act as a repartitioning agent, and to increase
organomegaly [32,33]. Thus in sub-experiment 2 we eval-
uated the role of this hormone in adipogenesis. However
despite the consistent elevation of the hormone in circu-
lation in pigs euthanized post FW for 48 h, the difference
was not significant and may point towards the lack of cel-
l u l a rr e s p o n s et oF Wi nt h ep i g s .H o w e v e r ,t h eo b s e r v e d
result perhaps represents the lack of sequential blood
sampling and further definition of GH baseline, ampli-
tude, mean overall and GH spike frequency. Further stu-
dies are required to examine GH secretory variables in
more detail in response to FW.
It is of interest that concurrent changes occurred in
AUC for glucose and lipogenic activity in the OM tissue,
which has been implicated in precipitation of metabolic
syndrome symptoms and progressively to type-2 diabetes
in humans [34]. The relationship among adipocyte size,
lipogenic activity and AUC of the glucose curve was initi-
ally highlighted by He et al. [14]. Since these associations
warranted further investigation, especially, because it has
been observed that adipose tissue from insulin sensitive
adults had greater lipogenic enzyme activity than those
from insulin resistant adults [5], the present study was
conducted with pigs to demonstrate associations among
FW regimen, glucose tolerance and glucose incorpora-
tion into fat in cells of varying diameter ranges. It can be
further hypothesized that periodic FW may produce
comparable effects as severe calorie restriction [35] or
bariatric surgery [36], where fasting glucose levels
declined significantly in type 2 diabetics prior to signifi-
cant weight loss and eventually leading to reversal of
type-2-diabetes. Similarly periodic FW for a determined
time may delay development of type-2 diabetes especially
if prudence in food consumption and energy utilization is
exercised between FW.
In conclusion the data supports the hypothesis that
FW enhances lipogenic potential of adipocytes especially
in the OM adipose tissue in pigs and can consistently
lower fasting and 120 min post glucose meal blood glu-
cose concentrations. The heightened lipogenic potential
of cells from pigs in the FWx4 treatment resides in cells
with diameter ranges of 91 to 118 μma n ds i g n i f i c a n t l y
in cells with the diameter range of 119-150 μm.
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